Wescap Management Group, Inc. Bristol Myers Squibb CO Transaction History

Wescap Management Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $232,123 - $271,903	-3,923 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $168,704 - $183,719	-2,725 Reduced 40.99%	3,923 $262,000
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $137,016 - $154,102	-2,309 Reduced 25.78%	6,648 $419,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $48,097 - $54,503	-833 Reduced 8.51%	8,957 $555,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $117,903 - $130,652	-2,053 Reduced 17.34%	9,790 $590,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $649,233 - $759,017	11,843 New	11,843 $696,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wescap Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Wescap Management Group, Inc. with notifications on news.